Skip to content

A study to check hair growth benefits

To evaluate the safety and efficacy of the test products in comparison to baseline in improving hair growth rate and reducing hair fall among healthy subjects - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063657
Enrollment
99
Registered
2024-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: XW-1 Hair oil: Apply the required quantity while making small partition across the scalp. Start from front and move to the back for uniform application Leave the oil for 30 minutes or o

Sponsors

Marico Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and female subjects in general good health. 2. Subjects in the age group 18-50 years (both the ages inclusive). 3. Subjects complaining of hair fall and damage. 4. Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol. 5. Hair density of greater than 100 and less than 200 hair follicle per square cm as per TrichoScan measurement 6. Male and female Subjects falling under Grade 3 - Grade 6 of hair loss severity grade evaluated as per MSCR photo numerical 10-point scale (Linear scale for assessment purpose-In Use Scale).

Exclusion criteria

Exclusion criteria: 1 Subjects who have undergone any kind of hair growth treatment in the last 3 months 2 Subjects having any active but controllable scalp disease which may interfere in the study assessments 3 Subjects who have taken chemotherapy for cancer in the 6 months prior to the studys start 4 Subjects who have history of crash dieting and or psychiatric disorder including trichotillomania 5 Subjects who have undergone hair transplant 6 A known history or present condition of allergic response or hypersensitivity to any topical or oral cosmetic pharmaceutical or nutraceutical product 7 Subjects on oral medications like topical or systemic corticosteroids undergoing any chemical hair salon treatment which will compromise the study 8 Subjects with chronic illness which may influence the cutaneous state 9 Subjects who are pregnant or nursing Self declared 10 Subjects with any history or present of underlying uncontrolled medical illness or any other serious medical illness

Design outcomes

Primary

MeasureTime frame
•Reduction in hair fall by comb test •Improvement in hair growth rate, hair thickness, hair density by TrichoScan and dermatological assessments •Change in anagen and telogen ratio by TrichoScanTimepoint: at Baseline, Week 2, Week 4, Week 8, Week 12

Secondary

MeasureTime frame
• Change in hair thinning by dermatologists • Overall safety of test product • Change in density of vellus hair & terminal hairTimepoint: at Baseline, Week 2, Week 4, Week 8, Week 12

Countries

India

Contacts

Public ContactDr Mukesh Ramnane

MS Clinical Research

mukesh.ramnane@msclinical.com08041125934

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026